Sarah B. Gitto

646 total citations
28 papers, 433 citations indexed

About

Sarah B. Gitto is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Sarah B. Gitto has authored 28 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 15 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Sarah B. Gitto's work include Immune Cell Function and Interaction (11 papers), Immunotherapy and Immune Responses (8 papers) and CAR-T cell therapy research (7 papers). Sarah B. Gitto is often cited by papers focused on Immune Cell Function and Interaction (11 papers), Immunotherapy and Immune Responses (8 papers) and CAR-T cell therapy research (7 papers). Sarah B. Gitto collaborates with scholars based in United States, Japan and Australia. Sarah B. Gitto's co-authors include Deborah A. Altomare, Alicja J. Copik, Jeremiah L. Oyer, Daniel J. Powell, Veethika Pandey, Otto Phanstiel, Fiona Simpkins, Dalia K. Omran, Alba Rodríguez-García and Hyoung Kim and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Sarah B. Gitto

27 papers receiving 428 citations

Peers

Countries citing papers authored by Sarah B. Gitto

Since Specialization

Citations

This map shows the geographic impact of Sarah B. Gitto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah B. Gitto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah B. Gitto more than expected).

Fields of papers citing papers by Sarah B. Gitto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah B. Gitto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah B. Gitto. The network helps show where Sarah B. Gitto may publish in the future.

Co-authorship network of co-authors of Sarah B. Gitto

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah B. Gitto. A scholar is included among the top collaborators of Sarah B. Gitto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah B. Gitto. Sarah B. Gitto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	[18F]FluorThanatrace PET imaging as a biomarker of response to PARP inhibitors in breast cancer 2025 ·Communications Medicine ·Sarah B. Gitto, Austin R. Pantel, Kara N. Maxwell, Daniel A. Pryma, Michael D. Farwell, Fang Liu, Quy Cao, (unknown), Amy S. Clark, (unknown), Elizabeth S. McDonald	4
2	[¹⁸F]Fluorthanatrace PET in Ovarian Cancer: Comparison with [¹⁸F]FDG PET, Lesion Location, Tumor Grade, and Breast Cancer Gene Mutation Status 2024 ·Journal of Nuclear Medicine ·(unknown), Austin R. Pantel, Sarah B. Gitto, Fang Liu, Erin K. Schubert, Daniel A. Pryma, Michael D. Farwell, David A. Mankoff, Robert H. Mach, Fiona Simpkins, Lilie L. Lin	0
3	PM21-particle stimulation augmented with cytokines enhances NK cell expansion and confers memory-like characteristics with enhanced survival 2024 ·Frontiers in Immunology ·Jeremiah L. Oyer, (unknown), (unknown), (unknown), Sarah B. Gitto, Joanna Mucha, Xiang Zhu, Deborah A. Altomare, Robert Y. Igarashi, Alicja J. Copik	3
4	Adoptive T cell therapy for ovarian cancer 2024 ·Gynecologic Oncology ·Sarah B. Gitto, (unknown), Daniel J. Powell	13
5	CD137+ tumor infiltrating lymphocytes predicts ovarian cancer survival 2024 ·Gynecologic Oncology ·(unknown), Monika A. Eiva, Fang Liu, Dalia K. Omran, Stefan Gysler, (unknown), (unknown), (unknown), Jin-Hee Oh, (unknown), Sarah B. Gitto, Daniel J. Powell	5
6	CHK1 inhibitor SRA737 is active in PARP inhibitor resistant and CCNE1 amplified ovarian cancer 2024 ·iScience ·Haineng Xu, Sarah B. Gitto, Gwo‐Yaw Ho, Sergey Medvedev, Kristy Shield‐Artin, Hyoung Kim, Sally Beard, Yasuto Kinose, (unknown), Holly E. Barker, (unknown), Wei‐Ting Hwang, Ryan J. Hansen, Bryan Strouse, Snezana Milutinovic, Christian A. Hassig, Matthew J. Wakefield, (unknown), (unknown), Fiona Simpkins	4
7	Leveraging immune resistance archetypes in solid cancer to inform next-generation anticancer therapies 2023 ·Journal for ImmunoTherapy of Cancer ·Kristin G. Anderson, David A. Braun, Aitziber Buqué, Sarah B. Gitto, Jennifer L. Guerriero, Brendan Horton, Bridget P. Keenan, Teresa S. Kim, Abigail E. Overacre-Delgoffe, Marco Ruella, Todd Triplett, (unknown), Vivek Verma, Fan Zhang	12
8	A B7-H4–Targeting Antibody–Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression 2023 ·Clinical Cancer Research ·Sarah B. Gitto, (unknown), Gareth Davies, Sushil Kumar, Krista Kinneer, Haineng Xu, Arthur Lewis, Srinivas Mamidi, (unknown), Hyoung Kim, Judith Anderton, (unknown), (unknown), Steven Coats, Robert W. Wilkinson, Eric J. Brown, Daniel J. Powell, Fiona Simpkins	16
9	Abstract 2896: Combination of cytokines and PM21-particle stimulation results in robust expansion of memory-like Natural Killer cells with enhanced survival 2023 ·Cancer Research ·Jeremiah L. Oyer, (unknown), Liza Robles‐Carrillo, (unknown), (unknown), Sarah B. Gitto, Joanna Mucha, Deborah A. Altomare, Robert Y. Igarashi, Alicja J. Copik	1
10	Induction of pancreatitis in mice with susceptibility to pancreatic cancer 2022 ·Methods in cell biology ·Sarah B. Gitto, (unknown), (unknown), Jignesh Parikh, Deborah A. Altomare	5
11	Humanized Patient-Derived Xenograft Models of Ovarian Cancer 2021 ·Methods in molecular biology ·Sarah B. Gitto, Erin George, Sergey Medvedev, Fiona Simpkins, Daniel J. Powell	3
12	Differential Expression of Polyamine Pathways in Human Pancreatic Tumor Progression and Effects of Polyamine Blockade on Tumor Microenvironment 2021 ·Cancers ·(unknown), Sarah B. Gitto, Veethika Pandey, Jignesh Parikh, Dirk Geerts, H. Carlo Maurer, Kenneth P. Olive, Otto Phanstiel, Deborah A. Altomare	20
13	PARP Theranostic Auger Emitters Are Cytotoxic in BRCA Mutant Ovarian Cancer and Viable Tumors from Ovarian Cancer Patients Enable Ex-Vivo Screening of Tumor Response 2020 ·Molecules ·Aladdin Riad, Sarah B. Gitto, Hwan Lee, Harrison D. Winters, (unknown), Chia‐Ju Hsieh, Kuiying Xu, Dalia K. Omran, Daniel J. Powell, Robert H. Mach, Mehran Makvandi	21
14	Identification of a novel IL-5 signaling pathway in chronic pancreatitis and crosstalk with pancreatic tumor cells 2020 ·Cell Communication and Signaling ·Sarah B. Gitto, (unknown), (unknown), Jeremiah L. Oyer, (unknown), Sally A. Litherland, Alicja J. Copik, Amr S. Khaled, (unknown), J. Pablo Arnoletti, Deborah A. Altomare	20
15	Of mice and men: pre-clinical models to identify therapy responsive patient subgroups 2020 ·Sarah B. Gitto, Daniel J. Powell	1
16	An autologous humanized patient-derived-xenograft platform to evaluate immunotherapy in ovarian cancer 2019 ·Gynecologic Oncology ·Sarah B. Gitto, Hyoung Kim, Stavros Rafail, Dalia K. Omran, Sergey Medvedev, Yasuto Kinose, Alba Rodríguez-García, (unknown), Haineng Xu, Lauren E. Schwartz, Daniel J. Powell, Fiona Simpkins	35
17	CAR T Cells Targeting MISIIR for the Treatment of Ovarian Cancer and Other Gynecologic Malignancies 2019 ·Molecular Therapy ·Alba Rodríguez-García, (unknown), Mathilde Poussin, Alina C. Boesteanu, Nicholas G. Minutolo, Sarah B. Gitto, Dalia K. Omran, Matthew K. Robinson, Gregory P. Adams, Fiona Simpkins, Daniel J. Powell	32
18	PD-L1 blockade enhances anti-tumor efficacy of NK cells 2018 ·OncoImmunology ·Jeremiah L. Oyer, Sarah B. Gitto, Deborah A. Altomare, Alicja J. Copik	118
19	Anti-ovarian tumor response of donor peripheral blood mononuclear cells is due to infiltrating cytotoxic NK cells 2016 ·Oncotarget ·Veethika Pandey, Jeremiah L. Oyer, Robert Y. Igarashi, Sarah B. Gitto, Alicja J. Copik, Deborah A. Altomare	14
20	Constitutively Active Akt1 Cooperates with KRasG12D to Accelerate In Vivo Pancreatic Tumor Onset and Progression 2015 ·Neoplasia ·(unknown), Veethika Pandey, Sarah B. Gitto, (unknown), (unknown), Jacqueline Talarchek, Andres J. Klein–Szanto, Joseph R. Testa, Deborah A. Altomare	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact